Clinical Trial Update: Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a study evaluating THR-18 for safety and efficacy in acute ischemic stroke patients treated with tPA, spanning Phase 1 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• THR-18

Snippet

Sponsor: Thrombotech Ltd. | Conditions: Acute Ischemic Stroke | Phase 1, Phase 2 | Status: UNKNOWN